当前位置:
X-MOL 学术
›
Expert Rev. Pharmacoecon. Outcomes Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
How do biosimilars sustain value, affordability, and access to oncology care?
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 1.8 ) Pub Date : 2020-09-08 , DOI: 10.1080/14737167.2020.1813570 Steven Simoens 1
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 1.8 ) Pub Date : 2020-09-08 , DOI: 10.1080/14737167.2020.1813570 Steven Simoens 1
Affiliation
(2021). How do biosimilars sustain value, affordability, and access to oncology care? Expert Review of Pharmacoeconomics & Outcomes Research: Vol. 21, Pharmacoeconomics in Oncology: Direct and Indirect Costs, pp. 327-329.
中文翻译:
生物仿制药如何维持价值、可负担性和获得肿瘤治疗的机会?
(2021)。生物仿制药如何维持价值、可负担性和获得肿瘤治疗的机会?药物经济学和结果研究的专家评论:卷。21,肿瘤学中的药物经济学:直接和间接成本,第 327-329 页。
更新日期:2020-09-08
中文翻译:
生物仿制药如何维持价值、可负担性和获得肿瘤治疗的机会?
(2021)。生物仿制药如何维持价值、可负担性和获得肿瘤治疗的机会?药物经济学和结果研究的专家评论:卷。21,肿瘤学中的药物经济学:直接和间接成本,第 327-329 页。